Mercè Boada

The AMBAR project: from rationale to Phase III RCT 10:13
The AMBAR project: from rationale to Phase III RCT
Mercè Boada • 20 Jul 2021
Reduced cognitive decline in the AMBAR trial of plasma exchange with albumin replacement for AD 17:02
Reduced cognitive decline in the AMBAR trial of plasma exchange with albumin replacement for AD
Mercè Boada • 20 Jul 2021
The first AMBAR center: towards therapy commercialization 4:23
The first AMBAR center: towards therapy commercialization
Mercè Boada • 20 Jul 2021
The content of VJNeurology is intended for healthcare professionals